Thu, July 28, 2022
Wed, July 27, 2022
Tue, July 26, 2022
Mon, July 25, 2022
Fri, July 22, 2022

Do Kim Maintained (TVTX) at Buy with Increased Target to $41 on, Jul 26th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-41-on-jul-26th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Do Kim of Piper Sandler, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Increased Target from $40 to $41 on, Jul 26th, 2022.

Do has made no other calls on TVTX in the last 4 months.



There are 2 other peers that have a rating on TVTX. Out of the 2 peers that are also analyzing TVTX, 0 agree with Do's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Do


  • Edward Nash of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $42 on, Thursday, July 14th, 2022
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $46 on, Tuesday, May 17th, 2022

Publication Contributing Sources